We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow
% of AUM
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
Eledon Pharmaceuticals
ELDN
$245M
| $92.4K | ﹤0.01% |
+23,459
| New | +$85.3K |
|
4052
ChargePoint
CHPT
$267M
| $92.4K | ﹤0.01% |
15,636
-690
| -4% | -$4.52K |
|
|
SEVN
4053
Seven Hills Realty Trust
SEVN
$171M
| $91.4K | ﹤0.01% |
10,846
-355
| -3% | -$2.96K |
|
|
KG
4054
Kestrel Group
KG
$59.3M
| $91.1K | ﹤0.01% |
10,125
-372
| -4% | -$4.13K |
|
4055
FTAI Infrastructure
FIP
$403M
| $90.8K | ﹤0.01% |
19,579
-1,946
| -9% | -$9.69K |
|
4056
Cognyte Software
CGNT
$626M
| $90.1K | ﹤0.01% |
+10,260
| New | +$97.3K |
|
4057
RxSight
RXST
$265M
| $88.6K | ﹤0.01% |
18,380
-19,945
| -52% | -$120K |
|
|
IGR
4058
CBRE Global Real Estate Income Fund
IGR
$681M
| $88.4K | ﹤0.01% |
19,178
+4,836
| +34% | +$22.5K |
|
4059
GraniteShares 2x Long COIN Daily ETF
CONL
$571M
| $88.3K | ﹤0.01% |
+20,686
| New | +$147K |
|
4060
Bausch Health
BHC
$2.45B
| $87.4K | ﹤0.01% |
17,728
-165
| -0.9% | -$885 |
|
4061
AirSculpt Technologies
AIRS
$201M
| $86.9K | ﹤0.01% |
+19,322
| New | +$78.3K |
|
4062
Humacyte
HUMA
$168M
| $86.9K | ﹤0.01% |
111,342
+6,223
| +6% | +$5.77K |
|
|
OGG
4063
Osisko Gold Group
OGG
$890M
| $86.6K | ﹤0.01% |
35,216
+550
| +2% | +$1.63K |
|
|
HIO
4064
Western Asset High Income Opportunity Fund
HIO
$329M
| $86.5K | ﹤0.01% |
23,770
+1,623
| +7% | +$5.92K |
|
4065
Health Catalyst
HCAT
$127M
| $86.3K | ﹤0.01% |
43,349
-47,973
| -53% | -$69.3K |
|
4066
Shattuck Labs
STTK
$681M
| $85.6K | ﹤0.01% |
12,335
| – | – |
|
|
IAUX
4067
i-80 Gold Corp
IAUX
$1.55B
| $83K | ﹤0.01% |
57,673
+60
| +0.1% | +$93 |
|
4068
PUT
Invesco QQQ Trust
QQQ
$490B
| $82.9K | ﹤0.01% |
+7,000
| New | +$4.82M |
|
4069
Xerox
XRX
$436M
| $82.9K | ﹤0.01% |
26,489
+15,959
| +152% | +$39.8K |
|
4070
BlackRock Enhanced International Dividend Trust
BGY
$536M
| $82.1K | ﹤0.01% |
14,309
+2,356
| +20% | +$13.5K |
|
4071
Aldeyra Therapeutics
ALDX
$89.3M
| $81.4K | ﹤0.01% |
38,200
+9,329
| +32% | +$16K |
|
4072
BlackRock TCP Capital
TCPC
$341M
| $80.6K | ﹤0.01% |
23,998
+9,283
| +63% | +$36K |
|
4073
SEALSQ Corp
LAES
$539M
| $80.5K | ﹤0.01% |
+25,562
| New | +$76.3K |
|
4074
Beyond Meat
BYND
$203M
| $80.2K | ﹤0.01% |
3,565
-2,060
| -37% | -$48K |
|
4075
Quanterix
QTRX
$127M
| $80.1K | ﹤0.01% |
+18,538
| New | +$60.1K |
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.